E. Moore

发表

Nanocomplex-based TP53 gene therapy promotes anti-tumor immunity through TP53- and STING-dependent mechanisms

C. Van Waes, E. Chang, Anthony D. Saleh, 2017, Oncoimmunology.

Dose-dependent enhancement of T-lymphocyte priming and CTL lysis following ionizing radiation in an engineered model of oral cancer.

James B. Mitchell, J. Friedman, R. Hodge, 2017, Oral oncology.

Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies

J. Schlom, J. Friedman, Lillian Sun, 2018, Journal of Immunotherapy for Cancer.

Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade via Attenuation of MDSC Recruitment and Function

J. Friedman, C. Allen, P. Clavijo, 2018, Cancer Immunology Research.

Fas ligand-deficient gld mice are more susceptible to graft-versus-host-disease.

M. V. D. van den Brink, J. Crawford, G. Murphy, 2000, Transplantation.

Graft-versus-host-disease-associated thymic damage results in the appearance of T cell clones with anti-host reactivity.

M. V. D. van den Brink, J. Ferrara, S. Burakoff, 2000, Transplantation.

Fas-Deficient lpr Mice Are More Susceptible to Graft-Versus-Host Disease1

M. V. D. van den Brink, J. Crawford, G. Murphy, 2000, The Journal of Immunology.

Fas-Deficientlpr Mice Are More Susceptible to Graft-Versus-Host Disease

J. Crawford, S. Burakoff, E. Moore, 1999 .

to Graft-Versus-Host Disease Mice Are More Susceptible lpr Fas-Deficient

J. Crawford, S. Burakoff, E. Moore, 1999 .

PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation

James B. Mitchell, C. Van Waes, J. Friedman, 2018, Oncoimmunology.

Intralesional Injection of Rose Bengal Induces a Systemic Tumor-Specific Immune Response in Murine Models of Melanoma and Breast Cancer

A. Sarnaik, L. Kuhn, K. Kodumudi, 2013, PloS one.

WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy

C. Van Waes, Zhong Chen, Anthony D. Saleh, 2018, Oncoimmunology.

Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ.

C. Van Waes, Zhong Chen, J. Friedman, 2017, Cancer research.

Cisplatin Alters Antitumor Immunity and Synergizes with PD-1/PD-L1 Inhibition in Head and Neck Squamous Cell Carcinoma

C. Van Waes, C. Allen, E. Moore, 2017, Cancer Immunology Research.

Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells

C. Van Waes, Zhong Chen, J. Friedman, 2017, Oncotarget.

Enhanced Tumor Control with Combination mTOR and PD-L1 Inhibition in Syngeneic Oral Cavity Cancers

C. Van Waes, R. Uppaluri, C. Allen, 2016, Cancer Immunology Research.

Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen–Specific T Cells

C. Van Waes, J. Friedman, H. Schreiber, 2019, Clinical Cancer Research.

mTOR and MEK1/2 inhibition differentially modulate tumor growth and the immune microenvironment in syngeneic models of oral cavity cancer

C. Van Waes, R. Uppaluri, C. Allen, 2015, Oncotarget.

Established T Cell–Inflamed Tumors Rejected after Adaptive Resistance Was Reversed by Combination STING Activation and PD-1 Pathway Blockade

C. Van Waes, C. Allen, E. Moore, 2016, Cancer Immunology Research.

Efficacy of intralesional injection with PV-10 in combination with co-inhibitory blockade in a murine model of melanoma

A. Sarnaik, K. Kodumudi, E. Moore, 2014, Journal of Immunotherapy for Cancer.

Antiretroviral Therapy Is Associated with a Decrease in Unintegrated HIV‐1 DNA in Pediatric Patients

R. Donovan, E. Moore, F. Cohen, 1994, Journal of acquired immune deficiency syndromes.

Dose-dependent enhancement of T-lymphocyte priming and CTL lysis following ionizing radiation in an engineered model of oral cancer.

James B. Mitchell, J. Friedman, R. Hodge, 2017, Oral oncology.